China | Analysis | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2015
Singapore: North China Pharmaceutical, ChinaChairman: Mr Yang HaijingRevenue: $1470 mnBusiness: Manufacturer and dist...Read more
Fiji health sector and China ink MOU
China | News | By BioSpectrum Bureau | 0 Comment | 15 Apr, 2015
Singapore: In a bid to improve the healthcare scenario of Fiji islands, the country's health minister Mr Jone Usamate ha...Read more
GE to build pharma plant for JHL Biotech in China
China | News | By BioSpectrum Bureau | 0 Comment | 26 Sep, 2013
Singapore: GE Healthcare Life Sciences, an unit of GE Healthcare, will build KUBio modular biopharmaceutical factory in ...Read more
China | Analysis | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2015
Singapore: SHENZHEN NEPTUNUS BIOENGINEERING, ChinaRevenue: $1533.1 mnChairman: Mr Simin ZhangBusiness: Manufacturer o...Read more
AAMG makes a foray into China's healthcare market
China | News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2015
Singapore: With a view to cash-in on the huge demand for medical expertise in China, home-grown healthcare company Asian...Read more
A re-think on site staff competency training required
China | Opinion | By BioSpectrum Bureau | 2 Comment | 05 Sep, 2013
When drugs are trialed in patients, they move into a clinical setting in which the busy routine care of patients, rath...Read more
FDA to add 10 new drug inspectors in China
China | News | By BioSpectrum Bureau | 0 Comment | 13 Dec, 2013
Singapore: In an effort to eliminate the weak industry oversight, the US drug regulatory body, the Food and Drug Adminis...Read more
Chinese luring Indian scientists to boost formulation business
China | News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2015
Singapore: In a new trend, Chinese drugmakers have been hiring Indian scientists, with a view to boost the country's for...Read more
Nutrastar marks steady revenue in Q2, 2015
China | Company results | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2015
Singapore: China based healthcare product supplier, Nutrastar International, has marked revenue of $13.24 million in thr...Read more
WuXi Healthcare Ventures raises $290M
China | News | By BioSpectrum Bureau | 0 Comment | 17 Dec, 2015
WuXi Healthcare Ventures announced the closing of its $290 million WuXi Healthcare Ventures II,exceeding its initial tar...Read more
Is India losing to China in the investment race?
China | Analysis | By BioSpectrum Bureau | 0 Comment | 17 May, 2012
While both India and China - both have a billion plus population - present similar pictures in terms of opportunities an...Read more
WuXi AppTec, Fudan Uni to jointly research on genomics
China | News | By BioSpectrum Bureau | 0 Comment | 08 Jun, 2015
Singapore: China's WuXi AppTec has partnered with Fudan University to bring WuXi NextCODE's population human genomics da...Read more
Start-up landscape in Southeast Asia
China | Analysis | By BioSpectrum Bureau | 0 Comment | 30 Apr, 2015
Singapore: The findings are surprising, mentions BVGH, as often it is the big pharmaceutical companies that invest larg...Read more
Asian firms lack antibody manufacturing capabilities
China | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2012
There are very few manufacturers in Asia capable of manufacturing antibodies on a large commercial scale. Manufacturing ...Read more
China hep B market to touch $1.4 bn by 2024'
China | Analysis | By BioSpectrum Bureau | 2 Comment | 01 Mar, 2016
Singapore: China will remain the largest major hepatitis B market over the next decade, rising from just under $923 mill...Read more
BioSpectrum award winner Biomics uses RNAi for therapeutics
China | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Biomics Biotechnologies, China, founded in February 2006, is on road to be counted as one of Asia's leading RNA interfer...Read more
Heartbeat Experts expands in BRICK
China | News | By BioSpectrum Bureau | 0 Comment | 13 Dec, 2012
Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, ann...Read more
Kotaro Yoshida: China, Japan are the new M&A hot spots
China | Opinion | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
Compared to 2011, global pharmaceutical and biotechnology sectors suffered a setback in the number of mergers and acquis...Read more